Fool - Investing News
02 Oct 2026, 01:00 UTC · 16h ago
Verdict
Headline takes no side. We score ABT +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Abbott Laboratories raised its full-year EPS guidance following a Q2 estimate beat.
Priced inanalysis of Q2 results reported earlier
So whatManagement's expectation for growth to accelerate in H2 suggests a potential beat in the next print.
More positive than 79% of claims this week
CVS Health beat analysts' expectations for revenue and adjusted EPS in its second-quarter 2026 results.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inanalysis of Q2 results reported earlier
So whatA high target price implies an upside of ~45% over the next year.
More positive than 66% of claims this week
Abbott Laboratories has increased its dividend payouts for 54 consecutive years.
Priced inmulti-year trend
So whatThe 64% dividend growth over five years provides a hedge against the 5.2% Treasury yield.
More positive than 44% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company has a long track record of dividend growth, beat Q2 estimates, and raised its full-year EPS guidance.
More positive than 88% of ticker scores this week
The company reported strong Q2 results beating expectations and has a 'strong buy' consensus among analysts with significant upside potential.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
45m ago
−0.2%
Price flat so far
$96.54 vs $96.69 close before publication (Oct 1) · not market-adjusted
ABT chart →
